---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-015847"
form_type: "8-K"
ticker: "CGC"
cik: "0001737927"
company_name: "Canopy Growth Corp"
filed_at: "2025-02-07T23:59:59+00:00"
generated_at: "2026-05-27T00:59:48.321232+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Canopy Growth Reports Q3 FY2025 Results: Revenue Down 5%, Adjusted EBITDA Improves 61%

## Summary
- Net revenue was $74.8M, down 5% YoY but up 8% excluding divestitures.
- Canada medical cannabis net revenue rose 16% to $19.6M; Storz & Bickel revenue up 19% to $22M.
- Adjusted EBITDA loss improved 61% to $3.5M; net loss from continuing operations was $121.9M.
- Total debt reduced to $442M from $554M at September 30, 2024, after early term loan prepayment.
- Claybourne infused pre-rolls launched in Canada, reaching #3 market share in BC and Ontario within 6 weeks.

## SEC filing metadata
- accession: 0000950170-25-015847
- form_type: 8-K
- ticker: CGC
- cik: 0001737927
- company_name: Canopy Growth Corp
- filed_at: 2025-02-07T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737927/000095017025015847/0000950170-25-015847-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737927/000095017025015847/cgc-20250207.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-015847
- JSON: https://secwatch.observer/filing/0000950170-25-015847.json
- Plain text: https://secwatch.observer/filing/0000950170-25-015847.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.